TD Cowen raised the firm’s price target on Aspen Aerogels to $30 from $20 and keeps a Buy rating on the shares. The firm said its impressive 1Q highlighted operating leverage and GM’s continued to ramp. The raised 2024 guidance assumes the low end of GM’s stated range, indicating conservatism.
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 55% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on ASPN:
- Aspen Aerogels Projects Financial Outlook for 2024
- Aspen Aerogels raises FY24 EPS view to greater than 3c from greater than (30c)
- Aspen Aerogels, Inc. Reports First Quarter 2024 Financial Results and Recent Business Highlights
- Aspen Aerogels reports Q1 EPS (2c), consensus (11c)
- Aspen Aerogels options imply 11.0% move in share price post-earnings